PASADENA, Calif., Dec. 15,
2023 /PRNewswire/ -- Alexandria Real Estate Equities,
Inc. (NYSE: ARE), the first, preeminent, longest-tenured and
pioneering owner, operator and developer of collaborative life
science, agtech and advanced technology mega campuses in AAA
innovation cluster locations, today announced that Novo Nordisk, a
leading global healthcare company, has executed a long-term
full-building lease at 60 Sylvan Road for 165,940 RSF to anchor the
Alexandria Center® for Life Science – Waltham1 mega campus in
Greater Boston. 60 Sylvan Road is
an active redevelopment project and is expected to deliver to Novo
Nordisk in 2025.
Designed to help attract and retain top talent and enhance
innovation and efficiency, the 1.5 million RSF Alexandria Center
for Life Science – Waltham mega
campus is highly differentiated in the Route 128 submarket with
inspiring design, curated placemaking and unmatched scale.
Alexandria is activating and
enhancing the mega campus with an exceptional suite of amenities,
including flexible conference and meeting space, an expansive
central lawn, collaboration pods, a casual café, a fitness and
wellness center, outdoor biking and walking paths and a vertical
farm. The campus is conveniently located in proximity to
world-renowned academic medical centers, as well as Cambridge, downtown Boston and Logan International Airport.
1 The Alexandria Center® for Life
Science – Waltham mega campus
includes 40, 50 and 60 Sylvan Road, 35 Gatehouse Drive and 840
Winter Street.
![Alexandria Center® for Life Science – Waltham mega campus (PRNewsfoto/Alexandria Real Estate Equities, Inc.) Alexandria Center® for Life Science – Waltham mega campus (PRNewsfoto/Alexandria Real Estate Equities, Inc.)](https://mma.prnewswire.com/media/2301601/12_15_23_ACLS_WalthamMegaCampus.jpg)
![60 Sylvan Road on the Alexandria Center® for Life Science – Waltham mega campus (PRNewsfoto/Alexandria Real Estate Equities, Inc.) 60 Sylvan Road on the Alexandria Center® for Life Science – Waltham mega campus (PRNewsfoto/Alexandria Real Estate Equities, Inc.)](https://mma.prnewswire.com/media/2301602/12_15_23_60_Sylvan_North_facade_reduced.jpg)
About Alexandria Real Estate
Equities, Inc.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P
500® company, is a best-in-class, mission-driven
life science REIT making a positive and lasting impact on the
world. As the pioneer of the life science real estate niche since
our founding in 1994, Alexandria
is the preeminent and longest-tenured owner, operator and developer
of collaborative life science, agtech and advanced technology mega
campuses in AAA innovation cluster locations, including
Greater Boston, the San Francisco Bay Area, New York City, San
Diego, Seattle,
Maryland and Research Triangle.
Alexandria has a total market
capitalization of $28.3 billion and
an asset base in North America of
75.1 million SF as of September 30,
2023, which includes 41.5 million RSF of operating
properties and 5.6 million RSF of Class A/A+ properties undergoing
construction, 8.9 million RSF of near-term and intermediate-term
development and redevelopment projects and 19.1 million SF of
future development projects. Alexandria has a longstanding and proven track
record of developing Class A/A+ properties clustered in life
science, agtech and advanced technology mega campuses that provide
our innovative tenants with highly dynamic and collaborative
environments that enhance their ability to successfully recruit and
retain world-class talent and inspire productivity, efficiency,
creativity and success. Alexandria
also provides strategic capital to transformative life science,
agrifoodtech, climate innovation and technology companies through
our venture capital platform. We believe our unique business model
and diligent underwriting ensure a high-quality and diverse tenant
base that results in higher occupancy levels, longer lease terms,
higher rental income, higher returns and greater long-term asset
value. For more information on Alexandria, please visit www.are.com.
Forward-Looking Statements
This press release includes "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
Such forward-looking statements include, without limitation,
statements regarding the impact of Alexandria's campus on Novo Nordisk's ability
to attract and retain top talent and enhance innovation and
efficiency; and the features and amenities of the Alexandria
Center® for Life Science – Waltham mega campus. These forward-looking
statements are based on Alexandria's present intent, beliefs or
expectations, but forward-looking statements are not guaranteed to
occur and may not occur. Actual results may differ materially from
those contained in or implied by Alexandria's forward-looking statements as a
result of a variety of factors, including, without limitation, the
risks and uncertainties detailed in its filings with the Securities
and Exchange Commission. All forward-looking statements are made as
of the date of this press release, and Alexandria assumes no obligation to update
this information. For more discussion relating to risks and
uncertainties that could cause actual results to differ materially
from those anticipated in Alexandria's forward-looking statements, and
risks and uncertainties to Alexandria's business in general, please refer
to Alexandria's filings with the
Securities and Exchange Commission, including its most recent
annual report on Form 10-K and any subsequently filed quarterly
reports on Form 10-Q.
CONTACT: Sara
Kabakoff, Senior Vice President – Chief Content Officer,
(626) 788-5578, skabakoff@are.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-announces-long-term-165-940-rsf-full-building-lease-with-novo-nordisk-for-rd-center-at-the-alexandria-center-for-life-science--waltham-mega-campus-in-greater-boston-302016208.html
SOURCE Alexandria Real Estate Equities, Inc.